Literature DB >> 11239339

Exercise, cardiovascular disease, and chronic heart failure.

R Humphrey1, M N Bartels.   

Abstract

UNLABELLED: In addition to patients with coronary artery disease, high-risk patients with severe congestive heart failure can benefit from rehabilitation. Traditionally, such patients were excluded from rehabilitation, but resistive exercise, higher-intensity programs, and interval training have now been safely conducted. Emerging data indicate that exercise training results in a number of improved physiologic and psychologic indices, including neural control, quality of life, exercise tolerance, ventricular function, skeletal muscle physiology, peripheral blood flow, and endothelial function. This review explores these beneficial outcomes through an assessment of therapeutic approaches, with special emphasis on the unique clinical characteristics of patients with congestive heart failure. OVERALL ARTICLE
OBJECTIVE: To describe the benefits and the evolving role of cardiac rehabilitation for patients with congestive heart failure.

Entities:  

Mesh:

Year:  2001        PMID: 11239339

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  4 in total

1.  Intermittent versus constant aerobic exercise: effects on arterial stiffness.

Authors:  Nicolas Tordi; Laurent Mourot; Eglantine Colin; Jacques Regnard
Journal:  Eur J Appl Physiol       Date:  2010-03       Impact factor: 3.078

2.  Exercise conditioning attenuates the hypertensive effects of nitric oxide synthase inhibitor in rat.

Authors:  Kazim Husain
Journal:  Mol Cell Biochem       Date:  2002-02       Impact factor: 3.396

Review 3.  Cardiac rehabilitation and artificial heart devices.

Authors:  Atsuko Ueno; Yasuko Tomizawa
Journal:  J Artif Organs       Date:  2009-06-18       Impact factor: 1.731

4.  Exercise-induced hypertension can increase the prevalence of coronary artery plaque among middle-aged male marathon runners.

Authors:  Chul-Hyun Kim; Yongbum Park; Min Young Chun; Young-Joo Kim
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.